Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis

OBJECTIVE: To assess the safety and efficacy of 2 repeated intrathecal injections of autologous bone marrow–derived mesenchymal stem cells (BM‐MSCs) in amyotrophic lateral sclerosis (ALS). METHODS: In a phase 2 randomized controlled trial (NCT01363401), 64 participants with ALS were randomly assigne...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Ki‐Wook, Noh, Min‐Young, Kwon, Min‐Soo, Kim, Hyun Young, Oh, Seong‐il, Park, Jinseok, Kim, Hee‐Jin, Ki, Chang‐Seok, Kim, Seung Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175096/
https://www.ncbi.nlm.nih.gov/pubmed/30048006
http://dx.doi.org/10.1002/ana.25302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175096/
https://www.ncbi.nlm.nih.gov/pubmed/30048006
http://dx.doi.org/10.1002/ana.25302

Ejemplares similares